B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy

Journal of Cardiology

Volumn 66, Issue 4, 2015, Pages 279-285

  Kainuma, Satoshi ^a,b   Taniguchi, Kazuhiro ^a   Toda, Koichi ^b   Shudo, Yasuhiro ^b   Takeda, Koji ^b   Funatsu, Toshihiro ^a   Miyagawa, Shigeru ^b   Kondoh, Haruhiko ^a   Nishi, Hiroyuki ^b   Yoshikawa, Yasushi ^b   Fukushima, Satsuki ^b   Hamada, Seiki ^b   Kubo, Koji ^a   Daimon, Takashi ^c   Sawa, Yoshiki ^b  

^a NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Advanced cardiomyopathy; Functional mitral regurgitation; Plasma B type natriuretic peptide; Restrictive mitral annuloplasty; Wall stress

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; MALE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEW YORK HEART ASSOCIATION CLASS; PROTEIN BLOOD LEVEL; RESTRICTIVE MITRAL ANNULOPLASTY; SURVIVAL; SYSTOLIC BLOOD PRESSURE; WALL STRESS; AGED; BLOOD; COMPLICATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; CARDIOMYOPATHIES; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NATRIURETIC PEPTIDE, BRAIN; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84939563631     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2015.02.015     Document Type: Article

References (28)

1. Koelling T.M., Aaronson K.D., Cody R.J., Bach D.S., Armstrong W.F. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002, 144:524-529.
2. Chan K.M., Punjabi P.P., Flather M., Wage R., Symmonds K., Roussin I., Rahman-Haley S., Pennell D.J., Kilner P.J., Dreyfus G.D., Pepper J.R. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 2012, 126:2502-2510. RIME Investigators.
3. Takeda K., Taniguchi K., Shudo Y., Kainuma S., Hamada S., Matsue H., Matsumiya G., Sawa Y. Mechanism of beneficial effects of restrictive mitral annuloplasty in patients with dilated cardiomyopathy and functional mitral annuloplasty. Circulation 2010, 122:S3-S9.
4. Bolling S.F., Deeb G.M., Brunsting L.A., Bach D.S. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995, 109:676-682.
5. Fattouch K., Guccione F., Sampognaro R., Panzarella G., Corrado E., Navarra E., Calvaruso D., Ruvolo G. Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg 2009, 138:278-285.
6. Paparella D., Malvindi P.G., Romito R., Iacoviello M., Visicchio G., Di Serio F., Favale S., de Luca Tupputi Schinosa L. BNP in mitral valve restrictive annuloplasty for ischemic mitral regurgitation. Int J Cardiol 2009, 137:57-60.
7. Wu A.H., Aaronson K.D., Bolling S.F., Pagani F.D., Welch K., Koelling T.M. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005, 45:381-387.
8. Mihaljevic T., Lam B.K., Rajeswaran J., Takagaki M., Lauer M.S., Gillinov A.M., Blackstone E.H., Lytle B.W. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007, 49:2191-2201.
9. Deja M.A., Grayburn P.A., Sun B., Rao V., She L., Krejca M., Jain A.R., Leng Chua Y., Daly R., Senni M., Mokrzycki K., Menicanti L., Oh J.K., Michler R., Wróbel K., et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012, 125:2639-2648.
10. Taniguchi K., Nakano S., Kawashima Y., Sakai K., Kawamoto T., Sakaki S., Kobayashi J., Morimoto S., Matsuda H. Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation 1990, 82:798-807.
11. Shudo Y., Taniguchi K., Takeda K., Sakaguchi T., Funatsu T., Matsue H., Miyagawa S., Kondoh H., Kainuma S., Kubo K., Hamada S., Izutani H., Sawa Y. Restrictive mitral annuloplasty with or without surgical ventricular restoration in ischemic dilated cardiomyopathy with severe mitral regurgitation. Circulation 2011, 124:S107-S114.
12. Rozich J.D., Carabello B.A., Usher B.W., Kratz J.M., Bell A.E., Zile M.R. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation: mechanism for differences in postoperative ejection performance. Circulation 1992, 86:1718-1726.
13. Janz R.F. Estimation of local myocardial stress. Am J Physiol 1982, 242:H875-H881.
14. Schuler G., Peterson K.L., Johnson A., Francis G., Dennish G., Utley J., Daily P.O., Ashburn W., Ross J. Temporal response of left ventricular performance to mitral valve surgery. Circulation 1979, 59:1218-1231.
15. Kainuma S., Taniguchi K., Toda K., Funatsu T., Miyagawa S., Kondoh H., Masai T., Otake S., Yoshikawa Y., Nishi H., Sakaguchi T., Ueno T., Kuratani T., Daimon T., Sawa Y. Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival. Eur J Heart Fail 2014, 16:189-200.
16. Kainuma S., Taniguchi K., Daimon T., Sakaguchi T., Funatsu T., Miyagawa S., Kondoh H., Takeda K., Shudo Y., Masai T., Ohishi M., Sawa Y. Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure. Circulation 2012, 126:205-213.
17. Kainuma S., Taniguchi K., Toda K., Funatsu T., Kondoh H., Nishino M., Daimon T., Sawa Y. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg 2011, 142:783-792.
18. Kainuma S., Taniguchi K., Toda K., Funatsu T., Kondoh H., Nishino M., Fujita S., Sawa Y. Restrictive mitral annuloplasty for functional mitral regurgitation: acute hemodynamics and serial echocardiography. Circ J 2011, 75:571-579.
19. Daniels L.B., Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 2007, 50:2357-2368.
20. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., Füchtbauer E.M., Dohrmann U., Beyersdorf F., Radicke D., Holubarsch C.J. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 2000, 102:3074-3079.
21. Iwanaga Y., Nishi I., Furuichi S., Noguchi T., Sase K., Kihara Y., Goto Y., Nonogi H. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006, 47:742-748.
22. Detaint D., Messika-Zeitoun D., Avierinos J.F., Scott C., Chen H., Burnett J.C., Enriquez-Sarano M. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005, 111:2391-2397.
23. Maeder M.T., Mariani J.A., Kaye D.M. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension 2010, 56:682-689.
24. Capomolla S., Febo O., Gnemmi M., Riccardi G., Opasich C., Caporotondi A., Mortara A., Pinna G.D., Cobelli F. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000, 139:596-608.
25. St John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., DeLurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Fisher W.G., Ellestad M., Messenger J., Kruger K., Hilpisch K.E., Hill M.R. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985-1990. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group.
26. Anand I.S., Fisher L.D., Chiang Y.T., Latini R., Masson S., Maggioni A.P., Glazer R.D., Tognoni G., Cohn J.N. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003, 107:1278-1283. Val-HeFT Investigators.
27. Dini F.L., Fontanive P., Conti U., Andreini D., Cabani E., De Tommasi S.M. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy. Am Heart J 2008, 155:1121-1127.
28. Westenberg J.J., van der Geest R.J., Lamb H.J., Versteegh M.I., Braun J., Doornbos J., de Roos A., van der Wall E.E., Dion R.A., Reiber J.H., Bax J.J. MRI to evaluate left atrial and ventricular reverse remodeling after restrictive mitral annuloplasty in dilated cardiomyopathy. Circulation 2005, 112:I437-I442.